MENU
BMA
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

BMA stock forecast, quote, news & analysis

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs... Show more

Industry: #Regional Banks
Interact to see
Advertisement
A.I.Advisor
published price charts
BMA
Daily Signal:
Gain/Loss:
A.I.Advisor
Oct 26, 2026

Why Banco Macro (BMA) Stock Is Down -14.5% in the Last 30 Days

Key Takeaways

  • Banco Macro shares have declined roughly 14.5% over the past 30 days, falling from about $68.86 to near $58.90, extending a broader multi-month downtrend.
  • The selloff accelerated in late October after an unexpected outcome in Brazil's presidential election triggered a sharp regional risk-off across Argentine ADRs.
  • Second-quarter 2026 results showed improved profitability, but management lowered its 2026 loan-growth guidance, citing subdued credit demand and rising delinquencies.
  • UBS cut its price target on the stock to $90 from $130 in mid-October while maintaining a Buy rating, reflecting reduced near-term confidence.
  • Over the trailing quarter, the shares are down roughly 34%, weighed down by credit normalization, election uncertainty, and weaker operating momentum.
  • For additional detail on the company, explore dedicated pages for Price Targets, Earnings, and Forecast.
  • Investors tracking systematic strategies can also explore Trending AI Robots for curated, algorithm-driven trading ideas.

Banco Macro (BMA) Company Overview and Market Position

Banco Macro S.A. is a universal Argentine bank and the private local lender with the largest branch network in the country. Headquartered in Buenos Aires, the bank serves low- and middle-income individuals as well as small and mid-sized companies through a nationwide footprint. As of the second quarter of 2026, it operated 402 branches and roughly 8,180 employees, serving about 6.36 million retail customers across 23 of Argentina's 24 provinces alongside more than 228,000 corporate clients.

The bank's scale rests on a low-cost, transaction-oriented deposit base, which represented about 76% of total liabilities, and on solid balance-sheet strength. It maintained a Tier 1 capital ratio near 28% and liquid assets equivalent to roughly 74% of deposits, while holding a private-sector loan market share of about 8.2%. Investors follow BMA as a proxy for Argentina's consumer banking recovery and for the country's broader macroeconomic and credit cycle.

Banco Macro (BMA) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, BMA declined approximately 14.5%, moving from a closing level near $68.86 in late September to about $58.90 in late October. The move was not a single-day event but rather a steady grind lower punctuated by sharper single-session drops in the final stretch of the period.

The quarterly picture is more pronounced. Roughly three months ago the stock traded near $89, meaning it has shed approximately 34% over the quarter. This places the recent 30-day decline within a longer slide that began after the shares peaked around the low $100s in mid-2026. The sustained downtrend reflects a combination of softening credit growth, asset-quality pressures, and rising political and macro uncertainty across Argentina and the broader region.

What Drove BMA Stock Price in the Last 30 Days

The most visible near-term catalyst was external. An unexpected result in Brazil's presidential runoff election in late October triggered a sharp selloff across Brazilian assets that spilled over into Argentine equities. In premarket trading, BMA was quoted down several percentage points alongside peers such as GGAL and YPF, as investors reassessed regional fiscal and political risk.

Company-specific factors compounded the pressure. When Banco Macro reported second-quarter 2026 results in August, net income rose 39% quarter-over-quarter to ARS 206.8 billion, and adjusted return on equity reached 14.3%. However, management cut its loan-growth guidance for the year, citing weaker credit demand and rising delinquencies. The reported non-performing loan ratio increased to 6.25% from 5.40% in the prior quarter, and consumer NPLs continued to climb, even as the bank's asset quality remained better than the system average.

Analyst actions also weighed on sentiment. In mid-October, UBS lowered its price target to $90 from $130 while retaining a Buy rating, signaling reduced conviction in near-term upside. Combined with a normalization in credit conditions and a pre-electoral backdrop in Argentina, these factors kept selling pressure intact through the month.

What Drove BMA Stock Performance Over the Last Quarter

The quarterly decline reflects a broader shift in the investment narrative surrounding Argentine banks. After a period of strong loan growth and improving profitability, the sector entered a phase of credit normalization. Banco Macro's lending growth slowed materially, and management guided toward more modest expansion for 2026, a signal that the favorable financing environment of prior years was cooling.

At the same time, asset-quality deterioration became a more prominent concern. While the bank's capital and liquidity remained robust, rising non-performing loans and lower coverage ratios prompted investors to reprice risk. Regional political uncertainty, including the outcome of Brazil's election and Argentina's own pre-electoral environment, added another layer of volatility. The result was a de-rating that erased a substantial portion of the stock's earlier gains, even as underlying earnings stayed resilient.

Trending AI Robots

Tickeron's Trending AI Robots page is a curated hub that highlights top-performing and currently relevant AI-driven trading bots. While the platform offers hundreds of bots that monitor thousands of tickers, only the most relevant and best-performing strategies appear in this section, helping traders filter out noise. These bots vary widely in strategy, holding timeframe, and performance metrics, so users can compare approaches that match their own objectives. The page provides a practical starting point for those interested in systematic, algorithm-based trading signals.

BMA Stock Forecast Drivers: What Investors Should Watch Next

Going forward, investors will focus on the trajectory of Argentina's credit cycle and Banco Macro's ability to stabilize loan growth while managing non-performing loans. Upcoming earnings releases will be closely watched for updated guidance on lending, net interest margin, and asset quality, particularly whether consumer delinquency trends begin to plateau.

Macroeconomic and political developments also remain central. Inflation, interest rates, and peso exchange-rate moves directly affect the bank's net interest income and funding costs, while Argentina's pre-electoral calendar and regional dynamics, including developments in Brazil, could keep volatility elevated. Analyst revisions and any changes to capital-return plans are additional signals to monitor. As always, these are factors to observe rather than a basis for any specific investment decision.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for BMA with price predictions
Oct 27, 2026

BMA's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BMA turned positive on October 13, 2026. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in 36 of 42 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMA's RSI Oscillator exited the oversold zone, 23 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 56 cases where BMA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

Following a +2.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in 235 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMA as a result. In 67 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The 50-day moving average for BMA moved below the 200-day moving average on September 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

The Aroon Indicator for BMA entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (0.001) is slightly lower than the industry average of (1.269). P/E Ratio (0.001) is within average values for comparable stocks, (13.240). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (1.190). Dividend Yield (0.031) settles around the average of (0.035) among similar stocks. BMA's P/S Ratio (1.824) is slightly lower than the industry average of (3.738).

The Tickeron Profit vs. Risk Rating rating for this company is 58 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock slightly worse than average.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Dividends

BMA paid dividends on July 14, 2026

Banco Macro SA BMA Stock Dividends
А quarterly dividend of $0.48 per share was paid with a record date of July 14, 2026, and an ex-dividend date of July 06, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are US Bancorp (NYSE:USB), PNC Financial Services Group (NYSE:PNC), Itau Unibanco Banco Holding SA (NYSE:ITUB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Huntington Bancshares (NASDAQ:HBAN), Banco Bradesco SA (NYSE:BBD), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.03B. The market cap for tickers in the group ranges from 148.16 to 173.74B. DBSDF holds the highest valuation in this group at 173.74B. The lowest valued company is VLYPP at 148.16.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was 1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 8%. SHFS experienced the highest price growth at 29%, while INTR experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was 32%. For the same stocks of the Industry, the average monthly volume growth was 95% and the average quarterly volume growth was 84%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 51
Price Growth Rating: 49
SMR Rating: 37
Profit Risk Rating: 56
Seasonality Score: 54 (-100 ... +100)
Why Banco Macro (BMA) Stock Is Down -14.5% in the Last 30 Days